A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer-Reference-Cited by-同舟云学术

A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer

Published:2009-07 Issue:7 Volume:20 Page:1178-1184
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Colleoni M.,Bagnardi V.,Rotmensz N.,Dellapasqua S.,Viale G.,Pruneri G.,Veronesi P.,Torrisi R.,Luini A.,Intra M.,Galimberti V.,Montagna E.,Goldhirsch A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/20/7/1178/977497/mdn747.pdf

Reference33 articles.

1. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer;Powles;J Clin Oncol,1995

2. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer;Fisher;J Clin Oncol,1998

3. The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27;Bear;J Clin Oncol,2003

4. Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors;Colleoni;Ann Oncol,2000

5. Primary chemo-therapy in breast invasive carcinoma: predictive value of the immuno-histochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi;MacGrogan;Br J Cancer,1996

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The predictive value of neutrophil-to-lymphocyte ratio for overall survival and pathological complete response in breast cancer patients receiving neoadjuvant chemotherapy;Frontiers in Oncology;2023-01-16

2. Stratification of Prognosis by Biological Features Following Neoadjuvant Chemotherapy in Luminal Breast Cancer;In Vivo;2022

3. GLO 1 and PKCλ Regulate ALDH1-positive Breast Cancer Stem Cell Survival;Anticancer Research;2021-11-30

4. Development, verification, and comparison of a risk stratification model integrating residual cancer burden to predict individual prognosis in early-stage breast cancer treated with neoadjuvant therapy;ESMO Open;2021-10

5. Development and validation of a risk stratification nomogram for predicting prognosis in bone metastatic breast cancer;Medicine;2021-02-12